Addressing challenges with Matching-Adjusted Indirect Comparisons to demonstrate the comparative effectiveness of entrectinib in metastatic ROS-1 positive Non-Small Cell Lung Cancer.
Saved in:
| Title: | Addressing challenges with Matching-Adjusted Indirect Comparisons to demonstrate the comparative effectiveness of entrectinib in metastatic ROS-1 positive Non-Small Cell Lung Cancer. |
|---|---|
| Authors: | Esnault C; Roche SAS, Boulogne-Billancourt, France., Baschet L; Horiana, Bordeaux, France. louise.baschet@horiana.com., Barbet V; Horiana, Bordeaux, France., Chenuc G; Biometry Department, IQVIA, Bordeaux, France., Pérol M; Medical Oncology Department, Centre Léon Bérard, Lyon, France., Thokagevistk K; Roche SAS, Boulogne-Billancourt, France., Pau D; Roche SAS, Boulogne-Billancourt, France., Monnereau M; Horiana, Bordeaux, France., Bosquet L; Health Data and Partnership Department, Unicancer, Paris, France., Filleron T; Biostatistics & Health Data Science Unit, Institut Claudius Régaud IUCT-O, Toulouse, France.; Université Paris-Saclay, CESP, INSERM U1018 Oncostat, Labeled Ligue Contre le Cancer, Villejuif, France. |
| Source: | BMC medical research methodology [BMC Med Res Methodol] 2025 Mar 01; Vol. 25 (1), pp. 57. Date of Electronic Publication: 2025 Mar 01. |
| Publication Type: | Journal Article; Comparative Study |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 100968545 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2288 (Electronic) Linking ISSN: 14712288 NLM ISO Abbreviation: BMC Med Res Methodol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1471-2288 |
|---|---|
| DOI: | 10.1186/s12874-025-02500-w |
